These data suggest that leptin may play an active role in hepatic fibrogenesis, in addition to its involvement in intrahepatic lipid metabolism, supporting the hypothesis that this adipokine acts as a mediator within the metabolic–inflammatory–fibrotic continuum of MASLD [1,30]. Here, LEP is linked to metabolic dysfunction-associated steatotic liver disease.